TerSera Therapeutics LLC
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- TerSera Therapeutics LLC
- Company name
- TerSera Therapeutics LLC
- Organisation type
- Industry
- Registered legal name
- TERSERA THERAPEUTICS LLC
- Registry sponsor category
- Industry
- Legal Entity Identifier (LEI)
- 549300HTUB2Y49PBR861
Related records
Trials (11)
- A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer
- A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer
- Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy
- Margetuximab Expanded Access Program
- Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
- Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.
- Phase 2 Study IV QUZYTTIRâ„¢ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine
- PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer
- Real-world Evidence Study EvaLuating PAtient-Reported Outcomes With XERMELO
- Telotristat With Lutathera in Neuroendocrine Tumors